HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • HealthEconomics.Com On-demand Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts

Voluntary Recall Guidance Released by FDA

The US Food and Drug Administration (FDA) issued its final guidance in April on initiating voluntary recalls for drugs, biologics, and medical devices. Although largely in line with the previous draft guidance issued in April 2019, the agency made changes based on public comments. The non-binding […]

more info 05/19/2022View Related Articles
Bookmark and Share

UCB’s Psoriasis Drug’s FDA Application on Pause Due to Facility Inspection Issues

UCB Biopharma

The US Food and Drug Administration (FDA) has temporarily halted the approval process for UCB’s psoriasis drug bimekizumab on concerns with facility inspections. This is the second delay UCB has faced thus far related to inspections, with the agency postponing the company’s application last October […]

more info 05/17/2022View Related Articles
Bookmark and Share

FDA Approves Eli Lilly Diabetes Drug

The US Food and Drug Administration (FDA) has given the green light to Eli Lilly’s new type II diabetes therapy Mounjaro. The injectable drug is hailed as a potential blockbuster for Lilly, which has seen its stocks jump by 50% in the past year. Clinical trial data showed that the drug reduced A1C […]

more info 05/16/2022View Related Articles
Bookmark and Share

Cytel Announces Free Statistical Programming Ebook

  When submitting data to the US Food and Drug Administration, maintaining a steady line of communications is essential. Frequent technical discussions can help ensure sufficiently thorough guidance from the agency and reduce snags in the process made by time-consuming corrections. In a […]

more info 05/12/2022View Related Articles
Bookmark and Share

FDA Roundup – Week of May 10th

In the latest weekly FDA roundup, the agency has approved the immunomodulatory COVID-19 drug for use in hospitalized adult patients needing external oxygen. This adds to the drug’s current indications, which include use in hospitalized children with COVID-19. In other news, the agency just posted a […]

more info 05/11/2022View Related Articles
Bookmark and Share

FDA Creates New Training Program for mRNA Vaccine Manufacturing Inspectors

As mRNA technology has been thrust into the mainstream with the advent of COVID-19 vaccines, the US Food and Drug Administration (FDA) has begun training new investigators to meet the increasing demand for mRNA vaccine manufacturing inspections. The trainees will undergo a mix of in-person, virtual […]

more info 05/05/2022View Related Articles
Bookmark and Share

CDER Director Requests Accelerated Approval Reforms and Expresses Worries over Recent Court Decisions

Patrizia Cavazzoni aired her concerns about recent court cases and made requests regarding accelerated approval reform in a recent hearing before the US Senate Health, Education, Labor, and Pensions Committee. Cavazzoni, Director of the enter for Drug Evaluation and Research (CDER) at the FDA, […]

more info 04/28/2022View Related Articles
Bookmark and Share

Webinar: Lessons Learned from Inspections and Audits During COVID-19

While the efforts and procedures of many regulatory bodies ground to a halt during the COVID-19 pandemic, the US Food and Drug Administration (FDA) pressed on with inspection. However, the agency’s tactics shifted as it adopted remote tools to connect with pharma and digital health companies before […]

more info 04/26/2022View Related Articles
Bookmark and Share

Language in FDA Decisions Could Signal Increased Scrutiny in Approval Decision-making

The wording in the US Food and Drug Administration’s (FDA) recent decision not to approve Pfizer and Myovant’s endometriosis application may signal a tightening of the agency’s standards for regulatory approval. The key phrase drawing attention is, “deficiencies that preclude discussion of labeling […]

more info 04/13/2022View Related Articles
Bookmark and Share

Fitbit Cleared by FDA for Afib Detection

The US Food and Drug Administration (FDA) has approved Fitbit’s algorithm for passive round the clock atrial fibrillation (afib) detection. The algorithm, validated in a 2020 study, uses photoplethysmography (PPG)  sensor technology, much like the technology used by the Apple Watch, which was […]

more info 04/11/2022View Related Articles
Bookmark and Share

  • 1
  • 2
  • 3
  • …
  • 29
  • Next Page

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • Senior Manager/Manager, RWE
  • Biostatistician/Statistical Analyst
  • Manager - Real World Evidence Engagement Lead (Remote- US)
  • Associate Director, Value & Access Strategy (Remote)
  • Manager, Value and Access Strategy (Remote- US)
 
Syndicated Reports

Economic & Related Consulting Service Revenues World Report & Database

Healthcare Analytical Testing Services Market worth $9.8 billion by 2026 – Key Players are Eurofins Scientific, SGS S.A., Charles River Laboratories

Risk-Based Monitoring Software Market Worth $511 Million By 2025 – Growing Number Of Clinical Trials To Propel Market Growth

Real-World Evidence Solutions Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)

 
White Papers

The Augmented Rep: A practical field force guide for the Omnichannel era

Rare Disease’s Star Turn

The Next Generation of Information Management

Risk Mitigation for Pharma Manufacturer Programs

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • HealthEconomics.Com On-demand Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts